Business NewsPR NewsWire • The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19

The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19

The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19

RYE BROOK, N.Y., Sept. 9, 2020 /PRNewswire/ -- With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first...

View More : https://www.prnewswire.com:443/news-releases/the-leukemia--lymphoma-society-launches-first-clinical-trial-specifically-f...
Releted News by prnewswire
Kraton Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer
SWK Holdings to Participate in 2020 Colliers Institutional Investor Conference
The Leukemia & Lymphoma Society Launches First Clinical Trial Specifically for Blood Cancer Patients with COVID-19
Jens Holtinger new head of Volvo's global truck production organization and member of the Volvo Executive Board
ASSIA announces EQUIPE™: Industry's first Work-From-Home Residential Connectivity Management Platform for SMB & Enterprise Markets
Compliance Solutions Strategies übernimmt AMFINE